Literature DB >> 35000137

Familial hyperkalemic hypertension: hyperkalemia not hypertension defines dominant KLHL3 disease and may permit earlier recognition and tailored therapy.

Meenakshi Sambharia1, Jyothsna Gattineni2, Lama Noureddine1, M Adela Mansilla3, Christie P Thomas4,5,6.   

Abstract

Entities:  

Keywords:  Gordon syndrome; Pseudo hypoaldosteronism type 2; Thiazides

Mesh：

Substances：

Year:  2022        PMID： 35000137     DOI： 10.1007/s40620-021-01217-5

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   4.393


× No keyword cloud information.
  6 in total

1.  KLHL3 regulates paracellular chloride transport in the kidney by ubiquitination of claudin-8.

Authors:  Yongfeng Gong; Jinzhi Wang; Jing Yang; Ernie Gonzales; Ronaldo Perez; Jianghui Hou
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

2.  Nephron Remodeling Underlies Hyperkalemia in Familial Hyperkalemic Hypertension.

Authors:  James A McCormick; David H Ellison
Journal:  J Am Soc Nephrol       Date:  2017-07-13       Impact factor: 10.121

Review 3.  Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.

Authors:  Juliette Hadchouel; David H Ellison; Gerardo Gamba
Journal:  Annu Rev Physiol       Date:  2016       Impact factor: 19.318

4.  A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.

Authors:  Karen I López-Cayuqueo; Maria Chavez-Canales; Alexia Pillot; Pascal Houillier; Maximilien Jayat; Jennifer Baraka-Vidot; Francesco Trepiccione; Véronique Baudrie; Cara Büsst; Christelle Soukaseum; Yusuke Kumai; Xavier Jeunemaître; Juliette Hadchouel; Dominique Eladari; Régine Chambrey
Journal:  Kidney Int       Date:  2018-07-07       Impact factor: 10.612

5.  Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.

Authors:  Lynn M Boyden; Murim Choi; Keith A Choate; Carol J Nelson-Williams; Anita Farhi; Hakan R Toka; Irina R Tikhonova; Robert Bjornson; Shrikant M Mane; Giacomo Colussi; Marcel Lebel; Richard D Gordon; Ben A Semmekrot; Alain Poujol; Matti J Välimäki; Maria E De Ferrari; Sami A Sanjad; Michael Gutkin; Fiona E Karet; Joseph R Tucci; Jim R Stockigt; Kim M Keppler-Noreuil; Craig C Porter; Sudhir K Anand; Margo L Whiteford; Ira D Davis; Stephanie B Dewar; Alberto Bettinelli; Jeffrey J Fadrowski; Craig W Belsha; Tracy E Hunley; Raoul D Nelson; Howard Trachtman; Trevor R P Cole; Maury Pinsk; Detlef Bockenhauer; Mohan Shenoy; Priya Vaidyanathan; John W Foreman; Majid Rasoulpour; Farook Thameem; Hania Z Al-Shahrouri; Jai Radhakrishnan; Ali G Gharavi; Beatrice Goilav; Richard P Lifton
Journal:  Nature       Date:  2012-01-22       Impact factor: 49.962

6.  Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.

Authors:  M Adela Mansilla; Ramakrishna R Sompallae; Carla J Nishimura; Anne E Kwitek; Mycah J Kimble; Margaret E Freese; Colleen A Campbell; Richard J Smith; Christie P Thomas
Journal:  Nephrol Dial Transplant       Date:  2021-01-25       Impact factor: 5.992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.